-
Active Trials
-
Phase 3
-
Phase 2
-
Phase 1
-
Results Pending
📊
Pipeline Summary
Expected Approvals
FDA Decision 1 upcoming PDUFA date
CagriSema (cagrilintide + semaglutide) Chronic weight management in adults with obesity or overweight NDA
Clinical Trials
Loading...